Exagen Inc. (XGN) has a market capitalization of $73.12M and trades at $3.04. The 52-week range is 2.59-12.23.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.3, Earnings Per Share (EPS) of $-0.93, annual revenue of $66.58M.
The stock has a beta of 1.94, operates in the Healthcare sector.
